Hoffman-La Roche receives FDA clearance to market oral ganciclovir for prevention of CMV

From: Transplant News | Date: December 17, 1996 | Copyright information

Hoffmann-La Roche, Nutley, NJ, announced it has received clearance from the Food and Drug Administration (FDA) to market oral ganciclovir (Cytovene (R) capsules) for the prevention of cytomegalovirus (CMV), a potentially life-threatening infection in recipients of solid organ transplants. The company reports the FDA decision was based on data which demonstrate that oral Cytovene given as prophylaxis reduced the overall incidence of CMV disease in liver transplant recipients by 78%.

CMV disease occurs in approximately 15%-30% of all solid organ transplant recipients - primarily in ...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

Combination therapy boosts CMV control
; ...the incidence of new cytomegalovirus (CMV) disease and delay progression of retinitis in...implant, can reduce the risk of both new CMV disease and Kaposi's sarcoma, as well as extend...protection from other manifestations of CMV disease. Previous studies have shown that oral...
Building acceptance for a costly product
; ...for prophylaxis of cytomegalovirus (CMV) disease that often follows renal transplantation...possible organ rejection because of CMV disease, which transplant recipients should...competes further complicated the endeavor. CMV disease significantly drives up the cost of...
CytoGam: Prophylaxis against CMV disease in various organ transplants
; ...CMV-IGIV) for prophylaxis against CMV disease associated with kidney, lung, liver...respectively (p < 0.01), and serious CMV disease was reduced from 46% to 13%. In addition...combination reduced the incidence of serious CMV disease below that expected from monotherapy...
Characterization of antibody response to human cytomegalovirus in India renal transplant patients
; Background & objectives: Cytomegalovirus (CMV) disease in seroendemic transplant populations...suggestive of its role in control of CMV disease despite reactivation as evidenced b...transplant recipients with symptomatic CMV disease with specific laboratory markers: renal...
Grapefruit juice and FK506, oral ganciclovir and CMV, using both kidneys from older donors research presented at ASTP, ASTS Annual Meetings
; ...ganciclovir reduced the occurrence of CMV disease by 79% when used as a prophylaxis as...Gene said. The six-month incidence of CMV disease was 19.5% in the placebo group of 152...is already approved for treatment of CMV disease in persons with AIDS. Another study...
Foscarnet therapy for congenital cytomegalovirus liver fibrosis following prenatal ascites
; ...shown. Our case suggests that congenital CMV disease following maternal recurrence may not...immunocompetent infants with congenital CMV disease. Key words: FOSCARNET; LIVER FIBROSIS...infection. In recent years, congenital CMV disease following recurrent maternal infection...
A pilot study on the role of cytomegalovirus & human herpesvirus-6 infections in Indian bone marrow transplant recipients
; ...strains9. Both these mechanisms could cause CMV disease in Indian transplant patients. After...HHV-6 seroconversion is a marker for CMV disease progression among liver transplant recipients...considered to be a potent co-factor in CMV disease progression22. Studies from Western...
CMV found to hide inside cells basic to disease-fighting immune system, researchers find
; ...highest levels of infection, reducing the risk of severe CMV disease in recipients, stated Dr. Karl Blume, director of the...clinicians more effectively protect recipients against CMV disease, possibly through the use of antiviral drugs.
Effect of Antiviral Chemoprophylaxis on Adverse Clinical Outcomes Associated With Cytomegalovirus After Liver Transplantation
; ...bacterial, fungal, and CMV infection and of CMV disease were recorded and compared. RESULTS...bacterial and fungal infection.4"7 Also, CMV disease increases the cost of care after liver...bacterial, fungal, and CMV infection and of CMV disease before retransplantation, death, or...
Polymerase chain reaction based restriction fragment length polymorphism for the genotyping of cytomegalovirus (CMV) from patients with CMV disease in Chennai
; ...the glycoprotein B subtypes in patients diagnosed to have CMV disease. Methods: CMV standard strain (AD 169) and 55 clinical specimens...Clinical Microbiology Laboratory with a clinical diagnosis of CMV disease. A total of 50 clinical specimens (14 blood, 16 urine, 8 aqueous...